Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
Queensland Health
Mallinckrodt
US Army
Deloitte
Harvard Business School
Colorcon
Farmers Insurance

Generated: October 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062387

« Back to Dashboard

NDA 062387 describes MYKINAC, which is a drug marketed by Alpharma Us Pharms and is included in two NDAs. Additional details are available on the MYKINAC profile page.

The generic ingredient in MYKINAC is nystatin. There are eight drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for 062387
Tradename:MYKINAC
Applicant:Alpharma Us Pharms
Ingredient:nystatin
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 062387

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength100,000 UNITS/GM
Approval Date:Jul 29, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
US Army
US Department of Justice
UBS
Julphar
Express Scripts
Deloitte
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.